BioGaia, which claims it is a leader in probiotic innovation backed by extensive research on the strain L. reuteri DSM 17938, has launched its first major marketing campaign in Australia to ...

If you’re looking for a probiotic supplement to support your digestive health, BioGaia Gastrus Chewable Tablets are worth considering. Pros Contains dual L. reuteri probiotic strains for ...

We highly recommend the Swanson L. Reuteri Probiotic Plus supplement for those looking to improve their digestive health and promote gut health. Pros Designed to release in the lower GI tract for ...

BioGaia develops, markets, and sells probiotic products focused on gut health, immune health, and oral health. The products are sold through local distribution partners or via own distribution in ...

BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners ...

Private equity firm EQT stepped into the market on Tuesday evening to sell 6.5% of BioGaia, Stockholm-based biotech company specialising in probiotics, in an accelerated bookbuild that raised ...

The global multistrain probiotics market is forecasted to be valued at US$ 156.25 billion by 2032, up from US$ 66 billion in 2022, advancing at a CAGR of 9% from 2022 to 2032. A burgeoning number of ...

BioGaia has patented a method to produce therapeutic microvesicles from probiotic bacteria for treating various conditions. The patent also covers isolated bacterial strains Bifidobacterium longum DSM ...

BioGaia has filed a patent for a method to enhance probiotic L. reuteri strains’ survival and activity in mammals by pre-conditioning with GOS during cultivation. The method involves growing the ...

The global multistrain probiotics market is forecasted to be valuated at US$ 156.25 billion by 2032, up from US$ 66 billion in 2022, advancing at a CAGR of 9% from 2022 to 2032. A burgeoning number of ...